In March 2016 it was announced that PreClinOmics had been acquired by CrownBio a wholly owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) CrownBo was itself acquired in Decemebr 2017 by JSR Life Sciences . ClinOmics Inc had been a preclinical contract research company primarily focused in supporting drug discovery and development research in the therapeutic areas of metabolic, renal, and cardiovascular diseases. The firm specializes in the design and execution of client studies in research areas such as metabolic syndrome, obesity, diabetes, cardiovascular, renal (including polycystic kidney disease), and neurology. The firmâs flexible workflow processes enable rapid transition from inquiry to study initiation while their technologies support a broad range of study designs, including QNMR, telemetry, Oxymax, Meso-Scale Discovery, chemiluminescence and rtPCR. The companies in-house breeding programs can also provide animal models for Metabolic Disease, (the ZDSD rat and FATZO mouse) and Polycystic Kidney Disease (PCY and JCK mouse) research
